Using a genetic screening platform developed by a UT Southwestern Nobel Laureate, scientists with the Center for the Genetics of Host Defense at UT Southwestern Medical Center have identified genetic mutations that contribute to nonalcoholic fatty liver disease (NAFLD), providing a potential future target for therapeutic interventions.
Scientists can determine which variation has infected a COVID-19 patient in only a few hours, a crucial process that often takes days or weeks in medical facilities but may have a significant impact on treatment choices